A retrospective study of 120 lung adenocarcinoma patients provided robust clinical evidence that high AGRN expression correlates with a greater susceptibility to lymph node metastases and a poorer prognosis [24]. This evidence concerns the gene AGRN and lung adenocarcinoma.